Sunesis Pharmaceuticals to Present at the C.E. Unterberg, Towbin Life Sciences Conference
October 24 2006 - 9:30AM
PR Newswire (US)
SOUTH SAN FRANCISCO, Calif., Oct. 24 /PRNewswire-FirstCall/ --
Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) today announced that
James W. Young, Ph.D., Executive Chairman, will present a corporate
update at the C.E. Unterberg, Towbin Life Sciences Conference on
Monday, October 30, 2006 at 3:30 p.m. Eastern Time at the Palace
Hotel in New York, NY. Interested parties may access an audio
webcast of the presentation by visiting the Sunesis website at
http://ir.sunesis.com/ . A replay of the webcast will be archived
on the "Calendar of Events" page in the Investors and Media section
of the Sunesis website for two weeks until November 13, 2006. About
Sunesis Pharmaceuticals Sunesis is a clinical-stage
biopharmaceutical company focused on the discovery, development and
commercialization of novel small molecule therapeutics for oncology
and other serious diseases. Sunesis has built a broad product
candidate portfolio through internal discovery and in-licensing of
novel cancer therapeutics. Sunesis is advancing its product
candidates through in-house research and development efforts and
strategic collaborations with leading pharmaceutical and
biopharmaceutical companies. For additional information on Sunesis
Pharmaceuticals, please visit http://www.sunesis.com/ .
Forward-Looking Statements This press release may contain
forward-looking statements that involve substantial risks and
uncertainties. Sunesis may not actually achieve the plans,
intentions or expectations contained in such forward-looking
statements. Actual results or events could differ materially from
the plans, intentions and expectations contained in such
forward-looking statements. Sunesis does not assume any obligation
to update any such forward-looking statements. DATASOURCE: Sunesis
Pharmaceuticals, Inc. CONTACT: investors, Eric Bjerkholt, CFO of
Sunesis Pharmaceuticals, Inc., +1-650-266-3717; or media, Karen L.
Bergman, +1-650-575-1509, or Michelle Corral, +1-415-794-8662, both
of BCC Partners, for Sunesis Pharmaceuticals, Inc. Web site:
http://www.sunesis.com/
Copyright
Sunesis Pharmaceuticals (NASDAQ:SNSS)
Historical Stock Chart
From Jun 2024 to Jul 2024
Sunesis Pharmaceuticals (NASDAQ:SNSS)
Historical Stock Chart
From Jul 2023 to Jul 2024